.png)
Designing cardiac assays for multi-year discovery and safety pipelines
Beyond Binding: iPSC-Based Functional Safety Screening in Oncology
Advancing Gene Therapy Potency Testing with iPSC-Based Systems
Revolutionizing Cardiac Safety Assessment with NHP Cardiomyocytes
A Reduction in Animal Testing Stems From Ncardia

Ncardia's iPSC Technology and the Shift from Animal Models
